Joseph Biederman

Joseph Biederman (29 September 1947 – 5 January 2023) was an American academic psychiatrist. He was Chief of the Clinical and Research Programs in Pediatric Psychopharmacology and Adult ADHD at the Massachusetts General Hospital and a professor of psychiatry at Harvard Medical School.

From 2019 to 2022, his citation metrics placed him in the top 0.01% of scientists across all fields. His research was and is highly cited: Biederman had a lifetime h-index of 121, which is one of the highest in the field of mental health. These metrics indicate that his publications have had a substantial impact on the field. Although his biggest focus was on attention-deficit/hyperactivity disorder (ADHD) in youth and adults, he also studied obsessive-compulsive disorder, bipolar disorder, tic disorders, depression, and substance use disorders in youth. Due to this work, he is regarded as the father of pediatric psychopharmacology. He attracted controversy and public attention for his role in promoting the diagnosis of childhood bipolar disorder and his financial ties to the pharmaceutical industry. Provided by Wikipedia